PSS26 - COST EFFECTIVENESS OF OCRIPLASMIN FOR TREATMENT OF SYMPTOMATIC VITREOMACULAR ADHESION IN THE UNITED STATES

Autor:	B. Lescrauwaet, Julia A. Haller, C. Bennison, R. Schmidt, Alan L. Wagner, A.M. Khanani, Pravin U. Dugel
Rok vydání:	2018
Předmět:	chemistry.chemical_compound medicine.medical_specialty chemistry Cost effectiveness business.industry Health Policy Ophthalmology Ocriplasmin Public Health Environmental and Occupational Health medicine medicine.disease business Vitreomacular adhesion
Zdroj:	Value in Health. 21:S427
ISSN:	1098-3015
DOI:	10.1016/j.jval.2018.09.2526
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::8713c41e8eaf0fde8fd6f0820bffa9b1 https://doi.org/10.1016/j.jval.2018.09.2526 Zobrazit plný text záznamu Full Text from ScienceDirect